Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver Meeting(R) 2018

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) will make two late-breaking poster presentations at The Liver Meeting(R) 2018, the Annual Meeting of the American Association for the Study of...

ARWR : 13.05 (-2.25%)
Major Biotech Announcements Moving the Market

HENDERSON, NV / ACCESSWIRE / October 10, 2018 / The biotech market is moved by events and announcements. There are a few major events currently impacting the companies highlighted below.

ARWR : 13.05 (-2.25%)
PPCHD : 1.2000 (+20.00%)
DVAX : 10.89 (-4.22%)
NVAX : 1.89 (-3.08%)
Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates

Arbutus Biopharma (ABUS) provides updates on its HBV development programs. However, uncertainty and early to mid-stage of development remains a concern.

ABUS : 4.34 (-2.25%)
ARWR : 13.05 (-2.25%)
JNJ : 139.05 (-0.32%)
GILD : 73.27 (-1.21%)
J&J Inks Deal With Arrowhead for Promising Liver Candidate

Johnson & Johnson (JNJ) signs a licensing pact with Arrowhead to develop the latter's RNAi therapy candidate, ARO-HBV, for treating chronic hepatitis B viral infection. The deal is worth $3.7 billion.

ARWR : 13.05 (-2.25%)
JNJ : 139.05 (-0.32%)
ALNY : 76.65 (-2.47%)
RHHBY : 30.5950 (+2.55%)
Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Amarin

NEW YORK, NY / ACCESSWIRE / October 5, 2018 / U.S. markets plunged on Thursday as the 10-year U.S. treasury note hit its highest level since 2011, dampening investors' enthusiasm for stocks. The Dow Jones...

ARWR : 13.05 (-2.25%)
Arrowhead Pharma Set to Possibly Rebound After Yesterday's Selloff of 16.11%

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $15.50 to a high of $20.31. Yesterday, the shares fell 16.1%, which took the trading range below the 3-day low of...

ARWR : 13.05 (-2.25%)
Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen

--- Arrowhead eligible to receive additional $3.5 billion in potential milestone payments, and potential further royalties on commercial sales

ARWR : 13.05 (-2.25%)
JNJ : 139.05 (-0.32%)
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to present at the following upcoming events:

ARWR : 13.05 (-2.25%)
Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development (R&D) Day to discuss its emerging pipeline of RNAi therapeutics that leverage its...

ARWR : 13.05 (-2.25%)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on September 14, 2018, the Board of Directors approved "inducement"...

ARWR : 13.05 (-2.25%)
Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?

Style Box ETF report for DWAS

ARWR : 13.05 (-2.25%)
DWAS : 50.27 (-2.14%)
CDNA : 24.55 (-0.73%)
INGN : 195.38 (-4.53%)
Arrowhead Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Arrowhead Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $18.42, changing hands for $19.39/share. When a stock reaches the target an...

ARWR : 13.05 (-2.25%)
Today's Research Reports on Stocks to Watch: Arrowhead Pharmaceuticals and Iovance Biotherapeutics

NEW YORK, NY / ACCESSWIRE / September 7, 2018 / Arrowhead Pharmaceuticals exploded on positive data results on Thursday while shares of Iovance Biotherapeutics were deep in the red on its own concerning...

ARWR : 13.05 (-2.25%)
IOVA : 9.89 (-9.43%)
Watch for Arrowhead Pharma to Potentially Pullback After Gaining 41.42% Yesterday

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $18.00 to a high of $22.39. Yesterday, the shares gained 41.4%, which took the trading range above the 3-day high...

ARWR : 13.05 (-2.25%)
Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit

--Up to 4.0 log10 reduction in HBsAg observed following three doses of ARO-HBV

ARWR : 13.05 (-2.25%)
Mimedx Group Inc has the Best Relative Performance in the Biotechnology Industry (MDXG , BCRX , LJPC , ARWR, EXAS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

LJPC : 16.16 (-4.89%)
MDXG : 5.31 (+2.51%)
ARWR : 13.05 (-2.25%)
BCRX : 7.16 (-0.42%)
Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to present at the following upcoming events:

ARWR : 13.05 (-2.25%)
New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MACOM Technology Solutions...

PTCT : 38.00 (-3.31%)
ARWR : 13.05 (-2.25%)
DAR : 19.88 (+1.02%)
TSCC : 0.0200 (+60.00%)
ELGX : 1.58 (-5.95%)
MTSI : 14.80 (-3.14%)
BOOT : 27.92 (+0.47%)
Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Perrigo Company

NEW YORK, NY / ACCESSWIRE / August 20, 2018 / U.S. equities continued to rally in Friday as hopes of easing trade tensions between the U.S. and China outweighed recent concerns of the currency crisis...

ARWR : 13.05 (-2.25%)
Invitae Corp is Among the Companies in the Biotechnology Industry with the Best Relative Performance (NVTA , INSY , ARWR, PTCT , BCRX )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

NVTA : 12.86 (-1.76%)
ARWR : 13.05 (-2.25%)
INSY : 8.91 (-2.20%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA -3.91
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures ended the Friday session with most contracts 3 to 4 cents in the red. Nearby Dec wiped out all of last week’s gains, down 1.81% since last Friday. There was a little harvest pressure, and some garden variety profit taking after hit...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar